Synthesis of catechol-functionalized polymer–based crosslinked thermoresponsive hydrogels for tissue-adhesive material
Source abstract
Abstract
Injectable and temperature-sensitive hydrogels were synthesized for use as a tissue-adhesive material between dopamine end-capped Pluronic and CCDP-q-PDB (2-chloro-3′,4′-dihydroxyacetophenone-quaternized poly((dimethyl aminoethyl methacrylate)-co-(t-butylmethacrylate))). The mixture of dopamine end-capped Pluronic and CCDP-q-PDB exists in a viscous solution state at room temperature, but becomes a gel via in situ crosslinking at body temperature. The hydrogel structure was shown to be more stable than Pluronic F127 copolymers in aqueous solution. At a 14:8 wt% ratio of dopamine end-capped Pluronic to CCDP-q-PDB, the sol quickly transformed into a gel at body temperature and under physiological conditions (<10 s), showing excellent gel stability. To evaluate the tissue-adhesive properties, the temperature-sensitive crosslinked dopamine end-capped Pluronic CCDP-q-PDB hydrogels, which can be applied for drug delivery, tissue engineering, and for use as tissue adhesives, were tested using a universal testing machine.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Polymer Surface Interaction Studies · Hydrogels: synthesis, properties, applications · Botulinum Toxin and Related Neurological Disorders
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical and Biological Engineering, Korea National University of Transportation, Chungju, South Korea
Department of IT Convergence, Korea National University of Transportation, Chungju, South Korea
Department of Polymer Science and Engineering, Korea National University of Transportation, Chungju, South Korea
References (25)
Show source-provided references
1. 10.1021/bm200464x10.1021/bm200464x ↗
2. 10.1016/S0969-806X(01)00427-310.1016/S0969-806X(01)00427-3 ↗
3. 10.1016/S0939-6411(96)00010-010.1016/S0939-6411(96)00010-0 ↗
4. 10.1097/00000658-196507000-0001710.1097/00000658-196507000-00017 ↗
5. 10.1021/jp072970f10.1021/jp072970f ↗
6. 10.1039/b919944f10.1039/b919944f ↗
7. 10.1126/science.114724110.1126/science.1147241 ↗
8. 10.1021/jp903588710.1021/jp9035887 ↗
9. 10.1016/j.ijpharm.2013.04.05310.1016/j.ijpharm.2013.04.053 ↗
10. 10.1002/mabi.20110026510.1002/mabi.201100265 ↗
11. Nahain AA · Macromol Res · 2012 · 20 · 92
12. 10.1021/la400268p10.1021/la400268p ↗
13. 10.1016/j.jiec.2011.11.05010.1016/j.jiec.2011.11.050 ↗
14. 10.1039/b912540j10.1039/b912540j ↗
15. 10.1039/c3nj00941f10.1039/c3nj00941f ↗
16. 10.1039/C5TB00779H10.1039/C5TB00779H ↗
17. 10.1002/mabi.20110008310.1002/mabi.201100083 ↗
18. 10.1016/j.eurpolymj.2014.04.02010.1016/j.eurpolymj.2014.04.020 ↗
19. 10.1016/j.actbio.2010.11.02910.1016/j.actbio.2010.11.029 ↗
20. 10.1039/c3tb20940g10.1039/c3tb20940g ↗
21. 10.1073/pnas.060555210310.1073/pnas.0605552103 ↗
22. 10.1016/j.jconrel.2015.09.01010.1016/j.jconrel.2015.09.010 ↗
23. 10.1016/j.jiec.2015.05.02110.1016/j.jiec.2015.05.021 ↗
24. 10.1177/088391150707851910.1177/0883911507078519 ↗
25. 10.1002/mabi.20120023410.1002/mabi.201200234 ↗